Recurrent mucormycosis - Better understanding of treatment and management

Karthika Panneerselvam; M Sathish Kumar; Karthikeyan; A Mathan Mohan

doi:10.4103/jfmpc.jfmpc_1220_20

Recurrent mucormycosis - Better understanding of treatment and management

J Family Med Prim Care. 2020 Dec 31;9(12):6279-6281. doi: 10.4103/jfmpc.jfmpc_1220_20. eCollection 2020 Dec.

Authors

Karthika Panneerselvam¹, M Sathish Kumar¹, Karthikeyan², A Mathan Mohan²

Affiliations

¹ Department of Oral Pathology and Microbiology, Karpaga Vinayaga Institute of Dental Sciences, Chinna Kolambakkam, Kanchipuram Dist., Madurantagam, Tamil Nadu, India.
² Department of Oral and Maxillofacial Surgery, Karpaga Vinayaga Institute of Dental Sciences, Chinna Kolambakkam, Kanchipuram Dist., Madurantagam, Tamil Nadu, India.

Abstract

Mucormycosis is a rare opportunistic, aggressive, fatal fungal infection. The fungal organisms are ubiquitous and easily affect immunocompromised patients. It is spread on inhalation, inoculation and wound contamination and is more common in diabetic and other immunocompromised individuals in a population. The clinical and radiological features of Mucormycosis can overlap with other conditions for which a thorough diagnosis should be made. The rate of recurrence in Mucormycosis cases is high. This article reports one such case in which recurrence occurred twice and was controlled only with resection. The main aim of this article is to emphasize the importance of practicing aggressive resection and also on regular follow up of the patient after surgical management. Knowledge on different diagnostic and treatment methods, availability of newer drugs and regular follow up can greatly help in the management and recurrence of Mucormycosis even in immunocompromised patients in a population where diabetes is more common and mortality of rhino cerebral form is high.

Keywords: Drugs; follow up; mucormycosis; recurrence; surgeries.

Publication types

Case Reports